OriCiro Genomics is Biotechnology in Japan that focus on synthetic biology business. Founded in 2018. They cover business area such as developer, a cell-free genome technology, cell-free synthesis, amplification, genome-scale large dna, synthetic biology, large DNA synthesis, manufacturing, gene therapy, pharmaceutical, food, agricultural sector.
2018
( 6 years old in 2024 )
Synthetic Biology
-
318 South Clinical Research Building
7-3-1 Hongo, Bunkyo-ku
Tokyo, 113-8485
Japan
Private
developera cell-free genome technologycell-free synthesisamplificationgenome-scale large dnasynthetic biologylarge DNA synthesismanufacturinggene therapypharmaceuticalfoodagricultural sector
* We use standard office opening hours in near OriCiro Genomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
OriCiro Genomics is Biotechnology business from Japan that founded in 2018 (6 years old in 2024), OriCiro Genomics business is focusing on Synthetic Biology.
OriCiro Genomics headquarter office and corporate office address is located in 318 South Clinical Research Building 7-3-1 Hongo, Bunkyo-ku Tokyo, 113-8485 Japan.
OriCiro Genomics was founded in Japan.
In 2024, OriCiro Genomics is currently focus on synthetic biology sector.
Above is snippet of Google Trends for "synthetic biology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with OriCiro Genomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
